After 27 years of proudly serving the clinical research community, CenterWatch Weekly is taking a break from publication to reimagine and refocus how best to serve your needs for thought leadership, insights, and training as we aim to accelerate research, together. We will keep you informed as new insights become available, and thank you for your continued support.
Read More
In an effort to improve access to clinical research in the US and ease enrollment challenges, the Milken Institute has published a new report focusing on distance as a barrier to trial participation, digging deep into demographics and distribution of trials across US counties, as well as offering an interactive map tool filterable by therapeutic area.
Read More
The FDA has finalized its guidance on crafting phase 3 clinical trials for devices designed to treat opioid use disorder (OUD), providing sponsors with direction on defining patient populations, recording medication use, monitoring drug use and other elements.
Read More
This week’s Pipeline features a phase 1 trial approval for progressive multiple sclerosis, a phase 2 trial start for lupus and an FDA drug approval for early symptomatic Alzheimer’s disease.
Read More
